LGND Holds Flat Base Pivot at 322.61 in Stage 2 Uptrend

Posted on by Eben@CANSLIM Research
LGND stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 2 (Advancing), as of October 26, 2026 at 00:49 — CANSLIM Research

Continue Reading

This article is for pass holders.

Already a pass holder? Sign in · Continue with Google

LGND is trading at 303.53, consolidating in a 15-week flat base with a depth of 14.7% and a pivot at 322.61, while holding above a rising 30-week moving average in a Stage 2 advance. The market is focused on this flat base formation, which follows a 67.1% move off the 52-week low and sits just 5.9% below the 52-week high, though no VCP contraction or breakout has yet been confirmed. Sentiment is bullish, with seven of eight trend template checks passing and an offensive setup in place.

LGND   Daily · data to 2026-10-23 close · 20 SMA 50 SMA 150 SMA
Frozen at publication – this chart does not move. Open live chart on TradingView →

SECTORHealthcareINDUSTRYBiotechnologyStage 2Weinstein stage
Data to US close: Fri 23 Oct 16:00 ET = Sat 24 Oct 04:00 HKTCreated: Mon 26 Oct 00:49 HKT = 12:49 ET

Inside the Full Report

  • 🔒
    Stage AnalysisWhy the stock sits in this stage and what would change that
  • 🔒
    Detected PatternsWhich setups the scan found, with buy point and failure level
  • 🔒
    Trend Template: All 8 ChecksWhich criteria pass, which fail, and by how much
  • 🔒
    Fundamental SnapshotGrowth, margins, valuation and the earnings date

Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Figures come from the scanned result (as of October 26, 2026) and company filings; all estimates not explicitly sourced from the provided data are clearly labeled as such. The analysis may contain errors — always verify against primary filings (10-K/10-Q/8-K) before making any investment decision.

Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Related Posts

Discover more from CANSLIM Research

Subscribe now to keep reading and get access to the full archive.

Continue reading